Skip to content
Sign in
Venture capitalBacked 1 network startup

Zero2IPO

Beijing VC/PE services group (founded 2000 by Gavin Ni, HK-listed since 2020); historical investor in Pleryon Therapeutics' Pre-A and Series A.

Beijing, China
Ticket
—Not published
Assets under management
—
Founded
2000
Stages
—
Network startups backed
1
Co-investors
4most often with EFung Capital

How they invest

Chinese venture and private-equity services (data, events, matching) plus fund investment. The Pleryon deals (Pre-A 2022, Series A 2025) show continued backing of a Hong Kong university biotech; broader thesis not recorded.

Stage and ticket

Observed Pre-A and Series A participation; ticket not recorded.

Geography

China.

What makes them say yes

  • China or Greater China company
  • Follow-on potential (observed repeat backing)
  • University-originated deep tech (observed)

Red flags

  • No China angle
  • Thesis otherwise undocumented

Sectors

Not published

Stages

Not published

Geographies

  • China

How to approach

Pleryon Therapeutics (co-backed by HKUST R&D Corporation, Efung Capital, Kaitai Capital) is the warm path.

Partners

  • Gavin NiFounder

Portfolio

1 network startup · no other company

One biotech backed across two rounds.

Gaps in the portfolio

  • Chinese industrial AI
  • Greater China medtech

Network startups

  • Pleryon TherapeuticsSWC 2026 Finalist

    HKUST polymer-therapeutics platform entering the clinic in dry eye, with osteoarthritis and aesthetics as follow-on indications.

    China · Biotech & life sciences

Network startups that fit

3 analysed

Chengdu industrial-AI company applying computer vision to safety monitoring and operations in energy and mining, with little public traction.

Chengdu industrial AI for energy and mining safety (50-99 staff): mainland Chinese tech, though traction is unverified.

30%confidence

Evidence from the records

  • “Industrial AI / computer vision for energy and mining”
  • “China”
Intro path
Pleryon founders (Zero2IPO portfolio).
First step
Request GranShoo customer references before introducing.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with EFung Capital, Kaitai Capital, and Lapam Capital

Sources

  1. 1innovationhub.hk/article/pleryon-therapeutics
  2. 2caplight.com/company/pleryon
  3. 3wikiwand.com/en/articles/Zero2IPO

Profile compiled from public sources. Unknown fields are left empty rather than estimated.